Organicell Regenerative Medicine, Inc., US68621D1072

Organicell Regenerative Medicine, Inc., US68621D1072

22.11.2022 - 17:36:46

EQS-News: OTCMKTS : OCEL - Organicell Starts Enrolling Long COVID Trial ?

22.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language: English Company: Organicell Regenerative Medicine, Inc.

United States ISIN: US68621D1072 EQS News ID: 1494035 ? End of News EQS News Service

1494035??22.11.2022?CET/CEST

@ dgap.de